US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 29.980
  • +1.240+4.31%
Close Nov 8 16:00 ET
  • 30.172
  • +0.192+0.64%
Post 20:01 ET
3.73BMarket Cap-14768P/E (TTM)

Apellis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
120.17%34.1M
94.45%-8.34M
25.13%-132.98M
-15.76%-594.74M
30.46%-97.88M
-9.50%-169.09M
-40.30%-150.16M
-59.21%-177.62M
8.77%-513.75M
-25.11%-140.74M
Net income from continuing operations
59.04%-57.45M
69.14%-37.66M
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
12.62%-652.17M
-12.21%-165.99M
Operating gains losses
--0
----
----
-99.64%120K
---32K
--133K
--0
--19K
-83.41%32.89M
--0
Depreciation and amortization
53.33%621K
-3.90%394K
-17.79%328K
14.59%1.7M
14.49%490K
13.45%405K
19.88%410K
10.83%399K
-0.34%1.49M
13.83%428K
Other non cash items
-89.86%658K
-52.32%3.11M
-8.41%6.14M
-8.27%26.29M
31.63%6.58M
-23.37%6.49M
-8.60%6.52M
-16.85%6.71M
353.03%28.66M
274.46%5M
Change In working capital
209.20%62.79M
90.48%-6.12M
-188.86%-103.38M
-1,175.12%-200.17M
-862.59%-42.56M
-102.44%-57.5M
-439.46%-64.33M
-1,863.19%-35.79M
83.21%-15.7M
89.16%-4.42M
-Change in receivables
143.56%25.42M
53.94%-36.58M
-158.28%-61.42M
-8,466.95%-198.72M
-10,284.38%-37.17M
-10,066.55%-58.36M
-6,578.55%-79.41M
-730.21%-23.78M
123.51%2.38M
104.88%365K
-Change in inventory
85.29%8.66M
17.77%-14.51M
-10,461.81%-14.92M
12.61%-60.65M
-84.18%-47.82M
141.33%4.67M
-13.11%-17.65M
100.87%144K
-325.30%-69.4M
-77.33%-25.96M
-Change in prepaid assets
150.80%5.19M
436.34%14.17M
-3,954.21%-4.34M
83.71%-1.87M
197.06%5.81M
-15.02%-10.22M
-13.55%2.64M
-132.04%-107K
14.89%-11.48M
21.48%-5.99M
-Change in payables and accrued expense
117.43%22.68M
48.67%33.51M
-26.38%-37.06M
183.75%35.12M
-17.35%31.47M
194.80%10.43M
288.20%22.54M
-978.52%-29.33M
12,928.42%12.38M
-16.13%38.08M
-Change in other current assets
120.76%837K
-114.07%-1.06M
-37.52%10.8M
-48.55%25.94M
147.19%5.15M
-219.97%-4.03M
-83.10%7.55M
29.69%17.28M
193.89%50.43M
80.66%-10.92M
-Change in other working capital
--0
---1.66M
--3.56M
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
120.17%34.1M
94.45%-8.34M
25.13%-132.98M
-15.76%-594.74M
30.46%-97.88M
-9.50%-169.09M
-40.30%-150.16M
-59.21%-177.62M
8.77%-513.75M
-25.11%-140.74M
Investing cash flow
Cash flow from continuing investing activities
0
75.81%-90K
-13.13%-293K
-101.13%-674K
-100.00%4K
-100.04%-47K
-100.45%-372K
99.90%-259K
-75.81%59.89M
46.07%124.13M
Net PPE purchase and sale
--0
75.81%-90K
-13.13%-293K
55.77%-674K
100.47%4K
76.02%-47K
4.86%-372K
-201.16%-259K
-38.17%-1.52M
-4,378.95%-851K
Net investment purchase and sale
----
----
----
--0
----
----
----
----
-75.31%61.42M
47.04%124.98M
Cash from discontinued investing activities
Investing cash flow
--0
75.81%-90K
-13.13%-293K
-101.13%-674K
-100.00%4K
-100.04%-47K
-100.45%-372K
99.90%-259K
-75.81%59.89M
46.07%124.13M
Financing cash flow
Cash flow from continuing financing activities
-55.76%2.54M
2,623.53%42.49M
-72.33%108.21M
7.89%394.5M
75.46%-3.91M
-40.37%5.75M
132.95%1.56M
3.82%391.11M
-6.78%365.66M
-104.15%-15.95M
Net issuance payments of debt
--0
----
----
----
----
--0
----
----
----
----
Net common stock issuance
--0
---98.76M
-74.31%98.76M
1.12%384.39M
--0
--0
--0
1.12%384.39M
-0.06%380.12M
--0
Proceeds from stock option exercised by employees
-55.60%2.56M
-80.24%5.16M
-46.51%9.48M
198.01%76.65M
616.45%27.09M
-45.89%5.76M
257.32%26.09M
342.95%17.72M
45.64%25.72M
-1.33%3.78M
Net other financing activities
-27.27%-14K
-835.09%-229.36M
99.75%-28K
-65.60%-66.54M
-57.16%-31M
98.90%-11K
-103.79%-24.53M
-48.31%-11M
-594.23%-40.18M
-8,223.63%-19.73M
Cash from discontinued financing activities
Financing cash flow
-55.76%2.54M
2,623.53%42.49M
-72.33%108.21M
7.89%394.5M
75.46%-3.91M
-40.37%5.75M
132.95%1.56M
3.82%391.11M
-6.78%365.66M
-104.15%-15.95M
Net cash flow
Beginning cash position
-41.45%361.43M
-57.33%327.03M
-36.30%352.3M
-13.82%553.07M
-22.54%453.5M
1.91%617.34M
20.68%766.36M
-13.82%553.08M
13.18%641.76M
105.20%585.45M
Current changes in cash
122.42%36.64M
122.86%34.06M
-111.75%-25.06M
-127.81%-200.91M
-212.59%-101.78M
-717.05%-163.39M
-416.71%-148.97M
3,233.39%213.23M
-214.95%-88.19M
-109.14%-32.56M
Effect of exchange rate changes
137.77%173K
827.66%342K
-473.21%-209K
127.66%135K
212.30%584K
-47.74%-458K
89.04%-47K
-12.50%56K
75.79%-488K
2,237.50%187K
End cash Position
-12.19%398.24M
-41.45%361.43M
-57.33%327.03M
-36.30%352.3M
-36.30%352.3M
-22.54%453.5M
1.91%617.34M
20.68%766.36M
-13.82%553.07M
-13.82%553.07M
Free cash flow
120.16%34.1M
94.40%-8.43M
25.07%-133.28M
-15.57%-595.51M
30.81%-97.97M
-9.39%-169.13M
-40.14%-150.53M
-59.32%-177.88M
8.68%-515.27M
-25.84%-141.6M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 120.17%34.1M94.45%-8.34M25.13%-132.98M-15.76%-594.74M30.46%-97.88M-9.50%-169.09M-40.30%-150.16M-59.21%-177.62M8.77%-513.75M-25.11%-140.74M
Net income from continuing operations 59.04%-57.45M69.14%-37.66M62.64%-66.42M18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M12.62%-652.17M-12.21%-165.99M
Operating gains losses --0---------99.64%120K---32K--133K--0--19K-83.41%32.89M--0
Depreciation and amortization 53.33%621K-3.90%394K-17.79%328K14.59%1.7M14.49%490K13.45%405K19.88%410K10.83%399K-0.34%1.49M13.83%428K
Other non cash items -89.86%658K-52.32%3.11M-8.41%6.14M-8.27%26.29M31.63%6.58M-23.37%6.49M-8.60%6.52M-16.85%6.71M353.03%28.66M274.46%5M
Change In working capital 209.20%62.79M90.48%-6.12M-188.86%-103.38M-1,175.12%-200.17M-862.59%-42.56M-102.44%-57.5M-439.46%-64.33M-1,863.19%-35.79M83.21%-15.7M89.16%-4.42M
-Change in receivables 143.56%25.42M53.94%-36.58M-158.28%-61.42M-8,466.95%-198.72M-10,284.38%-37.17M-10,066.55%-58.36M-6,578.55%-79.41M-730.21%-23.78M123.51%2.38M104.88%365K
-Change in inventory 85.29%8.66M17.77%-14.51M-10,461.81%-14.92M12.61%-60.65M-84.18%-47.82M141.33%4.67M-13.11%-17.65M100.87%144K-325.30%-69.4M-77.33%-25.96M
-Change in prepaid assets 150.80%5.19M436.34%14.17M-3,954.21%-4.34M83.71%-1.87M197.06%5.81M-15.02%-10.22M-13.55%2.64M-132.04%-107K14.89%-11.48M21.48%-5.99M
-Change in payables and accrued expense 117.43%22.68M48.67%33.51M-26.38%-37.06M183.75%35.12M-17.35%31.47M194.80%10.43M288.20%22.54M-978.52%-29.33M12,928.42%12.38M-16.13%38.08M
-Change in other current assets 120.76%837K-114.07%-1.06M-37.52%10.8M-48.55%25.94M147.19%5.15M-219.97%-4.03M-83.10%7.55M29.69%17.28M193.89%50.43M80.66%-10.92M
-Change in other working capital --0---1.66M--3.56M----------------------------
Cash from discontinued investing activities
Operating cash flow 120.17%34.1M94.45%-8.34M25.13%-132.98M-15.76%-594.74M30.46%-97.88M-9.50%-169.09M-40.30%-150.16M-59.21%-177.62M8.77%-513.75M-25.11%-140.74M
Investing cash flow
Cash flow from continuing investing activities 075.81%-90K-13.13%-293K-101.13%-674K-100.00%4K-100.04%-47K-100.45%-372K99.90%-259K-75.81%59.89M46.07%124.13M
Net PPE purchase and sale --075.81%-90K-13.13%-293K55.77%-674K100.47%4K76.02%-47K4.86%-372K-201.16%-259K-38.17%-1.52M-4,378.95%-851K
Net investment purchase and sale --------------0-----------------75.31%61.42M47.04%124.98M
Cash from discontinued investing activities
Investing cash flow --075.81%-90K-13.13%-293K-101.13%-674K-100.00%4K-100.04%-47K-100.45%-372K99.90%-259K-75.81%59.89M46.07%124.13M
Financing cash flow
Cash flow from continuing financing activities -55.76%2.54M2,623.53%42.49M-72.33%108.21M7.89%394.5M75.46%-3.91M-40.37%5.75M132.95%1.56M3.82%391.11M-6.78%365.66M-104.15%-15.95M
Net issuance payments of debt --0------------------0----------------
Net common stock issuance --0---98.76M-74.31%98.76M1.12%384.39M--0--0--01.12%384.39M-0.06%380.12M--0
Proceeds from stock option exercised by employees -55.60%2.56M-80.24%5.16M-46.51%9.48M198.01%76.65M616.45%27.09M-45.89%5.76M257.32%26.09M342.95%17.72M45.64%25.72M-1.33%3.78M
Net other financing activities -27.27%-14K-835.09%-229.36M99.75%-28K-65.60%-66.54M-57.16%-31M98.90%-11K-103.79%-24.53M-48.31%-11M-594.23%-40.18M-8,223.63%-19.73M
Cash from discontinued financing activities
Financing cash flow -55.76%2.54M2,623.53%42.49M-72.33%108.21M7.89%394.5M75.46%-3.91M-40.37%5.75M132.95%1.56M3.82%391.11M-6.78%365.66M-104.15%-15.95M
Net cash flow
Beginning cash position -41.45%361.43M-57.33%327.03M-36.30%352.3M-13.82%553.07M-22.54%453.5M1.91%617.34M20.68%766.36M-13.82%553.08M13.18%641.76M105.20%585.45M
Current changes in cash 122.42%36.64M122.86%34.06M-111.75%-25.06M-127.81%-200.91M-212.59%-101.78M-717.05%-163.39M-416.71%-148.97M3,233.39%213.23M-214.95%-88.19M-109.14%-32.56M
Effect of exchange rate changes 137.77%173K827.66%342K-473.21%-209K127.66%135K212.30%584K-47.74%-458K89.04%-47K-12.50%56K75.79%-488K2,237.50%187K
End cash Position -12.19%398.24M-41.45%361.43M-57.33%327.03M-36.30%352.3M-36.30%352.3M-22.54%453.5M1.91%617.34M20.68%766.36M-13.82%553.07M-13.82%553.07M
Free cash flow 120.16%34.1M94.40%-8.43M25.07%-133.28M-15.57%-595.51M30.81%-97.97M-9.39%-169.13M-40.14%-150.53M-59.32%-177.88M8.68%-515.27M-25.84%-141.6M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Gene Editing
Gene Editing
Intraday+1.71%